Galectin Therapeutics Inc.

GALTNASDAQUSD
2.45 USD
0.19 (8.41%)AT CLOSE (11:59 AM EDT)
2.39
0.06 (2.41%)
POST MARKET (AS OF 05:38 PM EDT)
Post Market
AS OF 05:38 PM EDT
2.39
0.06 (2.41%)
🔴Market: CLOSED
Open?$2.31
High?$2.49
Low?$2.29
Prev. Close?$2.26
Volume?540.5K
Avg. Volume?374.9K
VWAP?$2.41
Rel. Volume?1.44x
Bid / Ask
Bid?$2.30 × 1.7K
Ask?$2.54 × 100
Spread?$0.24
Midpoint?$2.42
Valuation & Ratios
Market Cap?161.3M
Shares Out?65.8M
Float?45.2M
Float %?70.0%
P/E Ratio?N/A
P/B Ratio?-1.26
EPS?-$0.47
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.42Strong
Quick Ratio?2.42Strong
Cash Ratio?2.21Strong
Debt/Equity?-0.26Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
-1.26CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-8.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
24.2%STRONG
ROA?
-158.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$176.3M
News
Profile
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Employees
9
Market Cap
161.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2002-09-04
Address
4960 PEACHTREE INDUSTRIAL BOULEVARD
NORCROSS, GA 30071
Phone: 678-620-3186